XETRA - Delayed Quote EUR

Sartorius Aktiengesellschaft (SRT.DE)

Compare
168.40 -1.60 (-0.94%)
As of 11:48 AM GMT+1. Market Open.
Loading Chart for SRT.DE
DELL
  • Previous Close 170.00
  • Open 171.00
  • Bid 168.00 x 18800
  • Ask 169.20 x 13500
  • Day's Range 168.20 - 173.80
  • 52 Week Range 164.80 - 290.00
  • Volume 427
  • Avg. Volume 3,426
  • Market Cap (intraday) 12.971B
  • Beta (5Y Monthly) 0.94
  • PE Ratio (TTM) 151.71
  • EPS (TTM) 1.11
  • Earnings Date Jan 28, 2025
  • Forward Dividend & Yield 0.73 (0.43%)
  • Ex-Dividend Date Apr 2, 2024
  • 1y Target Est 242.62

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.

www.sartorius.com

13,762

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SRT.DE

View More

Performance Overview: SRT.DE

Trailing total returns as of 11/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SRT.DE
36.28%
DAX P
14.13%

1-Year Return

SRT.DE
22.90%
DAX P
20.10%

3-Year Return

SRT.DE
67.20%
DAX P
18.31%

5-Year Return

SRT.DE
4.14%
DAX P
44.61%

Compare To: SRT.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SRT.DE

View More

Valuation Measures

Annual
As of 11/19/2024
  • Market Cap

    13.09B

  • Enterprise Value

    17.01B

  • Trailing P/E

    153.15

  • Forward P/E

    34.36

  • PEG Ratio (5yr expected)

    2.19

  • Price/Sales (ttm)

    3.53

  • Price/Book (mrq)

    4.40

  • Enterprise Value/Revenue

    5.12

  • Enterprise Value/EBITDA

    21.43

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.32%

  • Return on Assets (ttm)

    2.80%

  • Return on Equity (ttm)

    3.88%

  • Revenue (ttm)

    3.32B

  • Net Income Avi to Common (ttm)

    77.2M

  • Diluted EPS (ttm)

    1.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    579.2M

  • Total Debt/Equity (mrq)

    119.80%

  • Levered Free Cash Flow (ttm)

    259.78M

Research Analysis: SRT.DE

View More

Company Insights: SRT.DE

Research Reports: SRT.DE

View More

People Also Watch